FemTech: Gameto Secures $44M to Advance Stem Cell Therapy for Infertility and Menopause

What You Should Know: – Gameto, a clinical-stage biotechnology company focused on reproductive health secures $44M in Series C funding, bringing its total capital raised to a leading $127M. – The funding, led by Overwater Ventures with participation from multiple investors including Insight Partners and RA Capital, will support the completion of the ongoing Phase ... Read More